Navigation Links
RIFM Board Names New President

WOODCLIFF LAKE, N.J., April 24, 2012 /PRNewswire-USNewswire/ -- The Chair of RIFM's Board of Directors, Dr. Sean G. Traynor, announced, "Dr. David K. Wilcox is the new president of the Research Institute for Fragrance Materials, Inc. (RIFM)."



Dr. Wilcox comes to RIFM from the Colgate-Palmolive Company in Piscataway, N. J. where he served as V.P., Product Safety, Regulatory and Quality. He succeeds Dr. Ladd W. Smith who retires at the end of May.

Dr. Wilcox represented Colgate, on a global scale, to scientific experts from governments, academia, NGOs, and to legislative representatives, shareholders, media and various consumer groups. Previously, he was with The Procter & Gamble Company as a toxicologist in Regulatory and Human and Environmental Safety. Dr. Wilcox also served as Associate Director of the Ophthalmic Research Center at The Eye and Ear Institute of Pittsburgh, Pittsburgh, Penn.; Assistant Professor of Microbiology, Biochemistry and Molecular Biology, University of Pittsburgh, School of Medicine, Pittsburgh, Penn.; and Instructor of Ophthalmology at the Harvard Medical School, Boston, Mass.

Dr. Wilcox received his B. S. in Biology from Clarion State College in Clarion, Penn and his Ph.D. in Biological Sciences from University of Pittsburgh, Pittsburgh, Penn.

"Dr Wilcox's experience has required him to communicate complex scientific and regulatory information to business partners in a clear manner, gaining alignment with both internal and external stakeholders, enabling the development of science-based strategic plans to address safety/regulatory issues," said Dr. Traynor, "These qualities will aid him in building on the legacy of his predecessor, Dr. Smith. We are grateful to Dr. Smith for his 14 years of service to the industry. RIFM has experienced significant evolution during his tenure."

RIFM is the international scientific authority for the safe use of fragrance materials. RIFM generates, evaluates and distributes scientific data on the safety assessment of fragrance raw materials found in personal and household care products. Through extensive research, testing and constant monitoring of all scientific literature available, RIFM maintains its Database as the most comprehensive source worldwide of physical-chemical, toxicological and eco-toxicological data associated with known fragrance and flavor materials. All of RIFM's scientific findings are evaluated by an independent Expert Panel—an international group of dermatologists, pathologists, toxicologists, reproduction, respiratory and environmental scientists. The Expert Panel evaluates the safety of fragrance ingredients under conditions of intended use and publishes their results in peer-reviewed scientific journals. The decisions of the Expert Panel regarding restrictions of use are also published in the IFRA Standards. For more information about RIFM and its activities, visit or e-mail

Contact: Marie Gartshore, Communications Manager
tel: 201.689.8089, ext. 111

SOURCE Research Institute for Fragrance Materials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CardioInsight Announces Appointment of Jim Bullock as Chairman of the Board of Directors
2. ADVENTRX Announces Establishment of Regulatory Advisory Board
3. Laureate Biopharma Names James D. Utterback to Board of Directors
4. Inaugural Meeting of the FirstMark Scientific Board of Advisors
5. Inovios Scientific Advisory Board Chairman Elected as a Fellow by the American Association for the Advancement of Science
6. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
7. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
8. Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
9. InspireMD Appoints Dr. James Barry to Its Board of Directors
10. Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board
11. BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Proove Biosciences, a ... their partnership with the Keck Medicine of the University of Southern California ... T.R.O.J.A.N. Study (Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and Phenotypic Association ...
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
(Date:10/12/2015)... Oct. 12, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... engaged in developing and commercializing novel treatments in oncology, ... Dennis Turpin , the Company,s former Senior Vice ... its Quebec City office.  ... Chief Executive Officer of the Company commented, "After a ...
(Date:10/12/2015)... ... October 12, 2015 , ... Dr. Carl Peck, MD, Chairman ... firm as a Premier Expert consultant. NDA Partners Premier Experts are top ... to the company's clients. Premier Experts collaborate to design and implement critical ...
Breaking Biology Technology:
(Date:9/29/2015)... , Sept. 29, 2015  iDAvatars is excited to be ... its product to market. The official announcement was recently made ... event in San Francisco , where ... powered by IBM Watson. "It is both an ... 100 companies to bring to market the cognitive power of ...
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
(Date:9/28/2015)... , September 28, 2015 According ... (Hardware & Software), Product (Scanner & Others), Application (Access ... Defense, & Others) & Geography Global - Forecast to ... to reach USD 3627.90 Million by 2020, at a ... Browse 65 market data T ables and ...
Breaking Biology News(10 mins):